1 Friedlander A M . Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.[J]. Journal of Biological Chemistry, 1986, 261(16):7123-6.
2 Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018[J]. Cell death and differentiation, 2018.
3 Kovacs S B , Miao E A . Gasdermins: Effectors of Pyroptosis[J]. Trends in Cell Biology, 2017:S0962892417300843.
4 Huyen, Trang, Ha, et al. Inflammasome as a Therapeutic Target for Cancer Prevention and Treatment[J]. Journal of Cancer Prevention, 2017, 22(2):62-73.
5 X Wang, H Li, Li W , et al. The role of Caspase-1/GSDMD-mediated pyroptosis in Taxol-induced cell death and a Taxol-resistant phenotype in nasopharyngeal carcinoma regulated by autophagy[J]. Cell Biology and Toxicology, 2020(6).
6 Wei Z , Sun Y , Li G , et al. Advances of research in cancer-associated inflammation and tumor microenvironments[J]. Chinese Journal of Clinical Oncology, 2018.
7 Orita H , Tanaka S , Watanabe S , et al. Abstract 3424: The efficacy of Gasdermin gene family for tumor marker in colorectal cancer[J]. Cancer Research, 2015, 75(15 Supplement):3424-3424.
8 Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins[J]. Journal of Digestive Diseases, 2018, 19.
9 Yu P , Wang H Y , Tian M , et al. Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells in vitro[J]. Acta Pharmacologica Sinica, 2019.
10 Draganov D , Gopalakrishna-Pillai S , Chen Y R , et al. X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death[J]. Scientific Reports, 2015, 5:16222.
11 Pizato N , Luzete B C , Kiffer L , et al. Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells[J]. Scientific Reports, 2018, 8(1):1952.
12 Aura M. Jiménez-Garduo a, Mónica G. Mendoza-Rodríguez a c, A U C , et al. IL-1β induced methylation of the estrogen receptor ERα gene correlates with EMT and chemoresistance in breast cancer cells[J]. Biochemical and Biophysical Research Communications, 2017, 490( 3):780-785.
13 M Mendoza-Rodríguez, Romero H A , EM Fuentes-Pananá, et al. IL-1β induces up-regulation of BIRC3, a gene involved in chemoresistance to doxorubicin in breast cancer cells[J]. Cancer Letters, 2017, 390:39-44.
14 Weizhao, Peng, Shuang, et al. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression[J]. Journal of Experimental & Clinical Cancer Research, 2015.
15 Ma F , Wang S H , Cai Q , et al. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer[J]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, 84:1249-1255.
16 Dong R , Liu G B , Liu B H , et al. Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma[J]. Cell Death & Disease, 2016, 7(6):e2278.
17 Alipoor F J , Asadi M H , Torkzadeh-Mahani M . MIAT lncRNA is overexpressed in breast cancer and its inhibition triggers senescence and G1 arrest in MCF7 cell line[J]. Journal of Cellular Biochemistry, 2018, 119(8).
18 Zhao W , D Geng, Li S , et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR‐20a‐5p/HMGA2 axis in breast cancer[J]. Cancer Medicine, 2018, 7(3):842-855.
19 Rogers C , Erk Es D A , Nardone A , et al. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation[J]. Nature Communications, 2019, 10(1).
20 Masashi M , Takao H , Manabu S , et al. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation[J]. Plos One, 2016, 11(11):e0166422.
21 Zhang, Jia, Huai, et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression[J]. Laboratory investigation, 2014, 94(1):52-62.
22 Jianwei, Gao, Xiangyu, et al. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non?small cell lung cancer.[J]. Oncology Reports, 2018.
23 Daeho, Shin, Hyun-Woo, et al. Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense[J]. Oncogene, 2018.
24 Chang Y Y , Kao M C , Lin J A , et al. Effects of MgSO4 on inhibiting Nod-like receptor protein 3 inflammasome involve decreasing intracellular calcium[J]. Journal of Surgical Research, 2018, 221:257-265.
25 Jiao Y , Wang L , Lu L , et al. The Role of Caspase-4 and NLRP1 in MCF7 Cell Pyroptosis Induced by hUCMSC-Secreted Factors[J]. Stem Cells International, 2020, 2020:1-14.
26 Hergueta-Redondo M , D Sarrio, Molina-Crespo N , et al. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer[J]. Oncotarget, 2016, 7(35).
27 F Ghiringhelli, Apetoh L , Tesniere A , et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.[J]. Nature Medicine, 2009, 15(10):1170-1178.
28 Wang Y , Zhang H , Xu Y , et al. NLRP3 induces the autocrine secretion of IL-1β to promote epithelial–mesenchymal transition and metastasis in breast cancer[J]. Biochemical and Biophysical Research Communications, 2021, 560(11):72-79.
29  Guo B , Fu S , Zhang J , et al. Targeting inflammasome/IL-1 pathways for cancer immunotherapy[J]. Scientific Reports, 2016, 6:36107.
30 Platnich J M , Muruve D A . NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways[J]. Archives of Biochemistry and Biophysics, 2019.
31 Strowig T , Henao-Mejia J , Elinav E , et al. Inflammasomes in health and disease[J]. Nature, 2012, 481(7381):278-286.
32 Place D E , Kanneganti T D . Recent advances in inflammasome biology[J]. Current Opinion in Immunology, 2017, 50:32-38.
33 张咪,陈江. lncRNA U62317.1-201 plays a role in tongue cancer by function as a sponge of the miR let7 family[C]// 2019第一届全国口腔颌面-头颈肿瘤学术大会——聚合引领、协同发展. 2019.
34 Zhang X , Zhang J , Zhao W , et al. Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway[J]. Cancer Gene Therapy, 2021(Suppl 1):1-14.
35 Zhang C , Dang D , Cong L , et al. Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis[J]. Cancer Medicine, 2021.
36 Tong H , Li T , Gao S , et al. An Epithelial-Mesenchymal Transition-Related Long Noncoding RNA Signature Correlates With The Prognosis And Progression In Bladder Cancer Patients[J]. Bioscience Reports, 2020, 41(1).
37 Belkacemi L , Jelks A , Chen C H , et al. Altered placental development in undernourished rats: role of maternal glucocorticoids[J]. Reproductive Biology and Endocrinology, 2011, 9(1):105.
38 Hafner-Bratkovi, Iva. The NLRC4 inflammasome: The pieces of the puzzle are falling into place[J]. Inflammasome, 2017, 3(1).
39 Wei, M. C . Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death[J]. Science, 2001, 292(5517):727-730.
40 Bo, Zhou, Jia-Yuan, et al. Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis.[J]. Cell Research, 2018.
41 Zhou Z , He H , Wang K , et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells[J]. Science, 2020, 368(6494):eaaz7548.
42 Sborgi L , S Rühl, Mulvihill E , et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death[J]. The EMBO Journal, 2016, 35(16).
43 Shaw P J , Lukens J R , Burns S , et al. Cutting Edge: Critical Role for PYCARD/ASC in the Development of Experimental Autoimmune Encephalomyelitis[J]. The Journal of Immunology, 2010, 184(9):4610-4614.
44 Liang A , Zhong S , Xi B , et al. High expression of PYCARD is an independent predictor of unfavorable prognosis and chemotherapy resistance in glioma[J]. Annals of Translational Medicine, 2021, 9(12):986-986.
45 Aniket, Parab, Sanit, et al. Identification of stably expressed genes for normalization of gene expression data in oral tumors: a preliminary analysis[J]. Oral Cancer, 2019, 3(3-4):49-58.
46 Meo A D , Batruch I , MD Brown, et al. Searching for Prognostic Biomarkers for Small Renal Masses in the Urinary Proteome[J]. International Journal of Cancer, 2019, 146(8).
47 Muzio? T , Pineda-Molina E , Ravelli R B , et al. Structural basis for budding by the ESCRT-III factor CHMP3.[J]. Developmental Cell, 2006, 10(6):821-830.
48 Wang Z , Wang X . miR‐122‐5p promotes aggression and epithelial‐mesenchymal transition in triple‐negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen‐activated protein kinase signaling[J]. Journal of Cellular Physiology, 2020, 235(3).
49 Shi T , Dong Y , Jing L , et al. High-throughput screening identifies CHMP4A associated with hypoxia-inducible factor 1[J]. Life Sciences, 2010, 87(19-22):604-608.
50 Yang R , Shang L N , Gui M A , et al. Expression of CHMP4A and TSPYL-2 in early esophageal cancer and their significance[J]. Chinese Journal of Clinical and Experimental Pathology, 2017.
51 Yorikawa C , Shibata H , Waguri S , et al. Human CHMP6, a myristoylated ESCRT-III protein, interacts directly with an ESCRT-II component EAP20 and regulates endosomal cargo sorting[J]. Biochemical Journal, 2005, 387(Pt 1):17-26.
52 Zheng Z Y , Cheng C M , Fu X R , et al. CHMP6 and VPS4A mediate recycling of Ras to the plasma membrane to promote growth factor signaling[J]. Oncogene, 2012, 31(43):4630-4638.
53 Schmalhofer O , Brabletz B T . E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer[J]. Cancer&Metastasis Reviews, 2009.
54 Brunton V G , Frame M C . Src and focal adhesion kinase as therapeutic targets in cancer[J]. Current Opinion in Pharmacology, 2008, 8(4):427-432.
55 Rong, Rui-ming, Tao, et al. Twist2 promotes kidney cancer cell proliferation and invasion via regulating ITGA6 and CD44 expression in the ECM-Receptor -Interaction pathway[J]. Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie, 2016, 81:453-459.
56 Tamura Y , Morikawa M , Tanabe R , et al. Anti‐pyroptotic function of TGF‐β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells[J]. Molecular Oncology, 2021.
57 Jang G B , Kim J Y , Cho S D , et al. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype[J]. Scientific Reports, 2015, 5:12465.
58 Chen Y , Zhang S , Wang Q , et al. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein[J]. Journal of Hematology & Oncology, 2017, 10(1):36.
59 Hedstr?M G , Berglund M , Molin D , et al. Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma[J]. British Journal of Haematology, 2010, 138(1):68-71.
60 Reddy S M , Reuben A , Barua S , et al. Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer[J]. Cancer Immunology Research, 2019.
61 Okano M , Oshi M , Butash A L , et al. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis[J]. International Journal of Molecular Sciences, 2019, 20(17).
62 Paek S H , Kim H G , Lee J W , et al. Circulating plasmacytoid and myeloid dendritic cells in breast cancer patients[J]. European Journal of Cancer, 2018, 92:S122.
63 Piao M , Jin R . Correlation of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio with prognosis of breast cancer[J]. Chinese Journal of Clinical Oncology, 2015.
64 Malka D , Boige V , Jacques N , et al. Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.[J]. Annals of Oncology, 2012, 23(4):919-927.
65 Cheng Y , Kai W , Ma W , et al. Cancer-associated fibroblasts are associated with poor prognosis in esophageal squamous cell carcinoma after surgery.[J]. International Journal of Clinical & Experimental Medicine, 2015, 8(2):1896-903.
66 Topalian S , Drake C , Pardoll D . Immune checkpoint blockade: a common denominator approach to cancer therapy.[J]. Cancer Cell, 2015, 27(4):450.
67 Tong J , Flavell R A , Li H B . RNA m6A modification and its function in diseases[J]. Frontiers of Medicine, 2018, 12(4).
68 D Rong, Sun G , Wu F , et al. Epigenetics: roles and therapeutic implications of non-coding RNA modifications in human cancers[J]. Molecular Therapy - Nucleic Acids, 2021, 25(D1):67-82.
69 Mozafarizadeh M , Omran S P , Kordestani Z , et al. Association of Obesity-Related Genetic Variants (FTO and MC4R) with Breast Cancer Risk: A Popu
70 Gong P , Shao Y , Yang Y , et al. Analysis of N6-methyladenosine (m6A) methyltransferase reveals METTL14 and ZC3H13 as tumor suppressor genes in breast cancer. 2020.
71 Dong X F , Wang Y , BF Huang, et al. Downregulated METTL14 Expression Correlates with Breast Cancer Tumor Grade and Molecular Classification[J]. BioMed Research International, 2020, 2020(6):1-6.
72 Shi Y , Zheng C , Jin Y , et al. Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation[J]. Frontiers in Oncology, 2020, 10.
73 Zhuang J , Lin C , Ye J . m6A RNA methylation regulators contribute to malignant progression in rectal cancer[J]. Journal of Cellular Physiology, 2020, 235.
74 Li Y , Zheng J N , Wang E H , et al. The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma[J]. PeerJ, 2020, 8:e10385.
75 Alipoor F J , Asadi M H , Torkzadehmahani M . LncRNA Miat Promotes Proliferation of Cervical Cancer Cells and Acts as an Anti-apoptotic Factor. 2017.
76 Ai-Ran W U , Jing W U , Xiao-Jie L I , et al. The Expression of Long Non-coding RNA MIAT in Breast Cancer with Different Molecular Subtypes and Its Relationships with Clinical Characteristics[J]. Labeled Immunoassays and Clinical Medicine, 2018.
77 吴锦, 丁克硕, 王浩,等. 乳腺癌中hsa-miR-24-3p的表达及临床意义[J]. 临床与实验病理学杂志, 2019(5):514-517.
78 Elkhouly A , Youness R , Gad M . LncRNA H19/miR-486-5p/miR-17-5p: A novel immunoregulatory loop regulating TNBC cellular recognition by cytotoxic T lymphocytes and natural killer cells[J]. European Journal of Cancer, 2020, 138.
79 宋立强, 张博淼, 薛伟男,等. 结肠癌组织中miR-129-5p,BDNF表达变化及意义[J]. 山东医药 2021年61卷19期, 5-8页, ISTIC PKU CA, 2021:黑龙江省青年科学基金资助项目.
80 Bastos D , Nagai M A . In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors[J]. PLOS ONE, 2020, 15.